GMP Cell Therapy Consumables Market Size is valued at USD 22.72 Bn in 2024 and is predicted to reach USD 312.91 Bn by the year 2034 at a 30.1% CAGR during the forecast period for 2025-2034. Good Manufacturing Practices (GMP) ensure that products are manufactured and maintained under good quality standards. Cell therapy development processes are complex and require good pharmaceutical systems and quality control (QC). The market growth is attr...
Report ID: 1929 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global RNA Therapy Clinical Trials Market Size is valued at USD 2.5 Bn in 2024 and is predicted to reach USD 3.6 Bn by the year 2034 at a 3.8% CAGR during the forecast period for 2025-2034. The process of testing and evaluating the safety and effectiveness of therapeutic interventions based on RNA molecules is referred to as RNA therapy clinical trials. RNA therapy is a large group of treatments that use various forms of RNA molecules to target ...
Report ID: 1964 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Global Genetically Engineered Animal Models & Services Market Size is valued at USD 1.4 Bn in 2024 and is predicted to reach USD 3.8 Bn by the year 2034 at a 10.3% CAGR during the forecast period for 2025-2034. Genetically Engineered Animal Models & Services entail the breeding of animals, primarily mice or rats, with altered genes to investigate human diseases, evaluate pharmaceuticals, and comprehend gene functions. Services encompass ...
Report ID: 3043 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
Clinical Laboratory Tests Market Size is valued at USD 125.34 billion in 2024 and is predicted to reach USD 291.98 billion by the year 2034 at an 8.9% CAGR during the forecast period for 2025-2034. The market for clinical laboratory tests is expanding due to factors like an aging population, an expansion in the prevalence of target diseases, and the development of creative solutions to suit the market's increased need for clinical testing. The...
Report ID: 1689 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Nanopore Sequencing Market Size was valued at USD 343.0 Mn in 2024 and is predicted to reach USD 1,949.5 Mn by 2034 at a 19.4% CAGR during the forecast period for 2025-2034. Nanopore sequencing is a novel, scalable method that enables direct, real-time examination of lengthy DNA or RNA fragments. The technique operates by tracking how an electrical current changes when nucleic acids move through a protein nanopore. The resultant signal is...
Report ID: 3033 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Gene Transfer Technologies Market Size was valued at USD 3.8 Bn in 2024 and is predicted to reach USD 10.1 Bn by 2034 at a 10.7% CAGR during the forecast period for 2025-2034. The market for gene transfer technologies (GTT) is the area of biotechnology that focuses on introducing genetic material into cells to improve biological processes, treat or prevent diseases, or increase agricultural qualities. In gene therapy, altered genes are inserte...
Report ID: 3034 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Novel T-Cell Immunotherapies Market is expected to grow at a 38.0% CAGR during the forecast period for 2025-2034. T-cell immunotherapy is a rapidly emerging field of oncology. T-cell therapies have come out as a promising option among the current targeted anti-cancer therapies due to their high target specificity, customization potential, ability to generate immunological memory, and minimal side effects. Some of the novel types of T-cell ther...
Report ID: 1020 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Nanozymes Market Size is predicted to grow at an 7.8% CAGR during the forecast period for 2025-2034. Nanozymes are nanomaterials with enzyme-mimicking catalytic properties, capable of replicating natural enzyme functions under physiological conditions. Typically composed of metals, metal oxides, or carbon-based structures, they offer advantages over natural enzymes such as enhanced stability, cost-efficiency, and resilience to extrem...
Report ID: 3023 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Cell and Gene Therapy Bioassay Services Market Size is estimated to grow at a 25.0% CAGR during the forecast period for 2025-2034. Cell and gene therapy focuses on modifying genetic material to improve functioning or treat a disease. These advanced therapies are one of the highest valued therapeutic segments within the biopharmaceutical industry and can address the most challenging diseases. Bioassay services play a critical role in...
Report ID: 1208 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Gene and Cell Therapies Targeting CNS Disorders Market is expected to grow at a 30.5% CAGR during the forecast period of 2025-2034. Key Industry Insights & Findings from the Report: The growing incidence of central nervous system (CNS) illnesses and the increasing need for efficient treatments are anticipated to propel the market for gene & cell therapies targeting CNS disorders. Increasing regulatory approvals for gene therap...
Report ID: 1258 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Pharmaceuticals